Abbreviations & Acronyms CI = confidence interval eGFR = estimated glomerular filtration rate IQR = interquartile range KUB = kidney, ureter and bladder X-ray MDRD = Modification of Diet in Renal Disease OR = odds ratio PCN = percutaneous nephrostomy PCNL = percutaneous nephrolithotomy SD = standard deviation Objectives: To share our 10-year experience of tract creation by using plasma vaporization compared with metal dilatation in percutaneous nephrolithotomy. Methods: We retrospectively reviewed the medical records of 230 patients who had undergone 244 percutaneous nephrolithotomy procedures at Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan, from January 2007 to December 2016, and divided the patients into the plasma (n = 130) and metal (n = 114) groups. All patients underwent percutaneous nephrolithotomy by either a bipolar resectoscope mounted with a plasma vaporization button electrode or metal dilatation for tract creation. Propensity score matching was applied to reduce selection bias. Perioperative and postoperative data analysis included procedure time, length of hospital stay, blood transfusion rate, any early and late complications, stone-free rate, renal function, and time of need for pain control. Results: Before propensity score matching, there were significantly shorter hospital stay (2.6 vs 3.8 days, P < 0.01), less operating time (66.1 vs 108.1 min, P < 0.01) and no blood transfusion rate (0 vs 4 [3.5%], P = 0.031) in the plasma vaporization group. After propensity score matching, there was no statistically significant difference in the patients' baseline characteristics. There were significantly shorter hospital stay (odds ratio 0.46, 95% confidence interval 0.32-0.66; P < 0.001) and shorter average operating time (odds ratio 0.98, 95% confidence interval 0.97-0.99, P < 0.001) in the plasma vaporization group. Conclusions: In comparison with metal dilatation, the plasma vaporization technique is a safe and effective method for creating the nephrostomy tract for percutaneous nephrolithotomy, based on shorter postoperative stay, less operating time, zero blood transfusion rate, acceptable stone-free rate and no major complications.
Introduction
One of the important steps in PCNL is nephrostomy tract creation. The most commonly applied three methods of tract dilatation are the one-step balloon dilator, Amplatz dilators and the Alken metal telescopic sequential dilator. 1 However, the balloon dilation technique is safer and more efficient than the metal telescopic dilation technique for tract dilation during PCNL. Furthermore, significant differences in transfusion rate were found between the balloon dilation and metal telescopic dilation groups. 1, 2 We have shown that the plasma vaporization technique is a better method for tract creation than balloon dilatation, with superior efficacy and a lower complication rate. 3 Therefore, we could suppose that the plasma vaporization technique is still a better method for tract creation than metal dilation. However, there is no head-to-head comparison of plasma vaporization and metal dilatation in the literature. The aim of the present study was to share our 10-year experience of tract creation by using plasma vaporization compared with metal dilatation in PCNL.
(between May 2010 and December 2016) or metal dilatation for tract creation (between January 2007 and December 2016). They were divided into plasma (n = 130) and metal (n = 114) groups. Propensity score matching was applied to reduce selection bias. After propensity score matching, there were 93 patients (n = 93) in each group. Perioperative and postoperative data analysis of before and after the matching included procedure time, length of hospital stay, blood transfusion rate, any early and late complications, stone-free rate, renal function, and time of need for pain control. There were three different surgeons in two groups with two (YT Cheng, WC Lee) in the metal dilatation group and one (PH Chiang) in the plasma vaporization group. All patients gave written informed consent before the PCNL procedure.
In the metal dilatation group, the nephrostomy tract was dilated with telescoping metal telescopic dilators (Richard Wolf GmbH, Knittlingen, Germany). The metal telescopic dilation system comprised seven stainless steel tubes that extended up to 27-Fr, overlapping at 3-Fr intervals from 9-Fr to 27-Fr. In the plasma vaporization group, we incised a longitudinal wound of approximately 1.5 cm around a PCN catheter and a 28-Fr Amplatz sheath was inserted into the subcutaneous area. There was no significant difference of tract size between the metal and plasma group. Under the working space of the Amplatz sheath, we used a bipolar resectoscope (TURis-PVP system; Olympus GmbH, Hamburg, Germany) combined with a plasma vaporization button electrode powered by the Olympus ESG-40 generator (Olympus) using the standard procedure (Fig. 1) . 3, 4 Plain abdominal film of the kidney, ureter and bladder was used to measure the diameter of residual stone fragments.
The stone-free rate was defined as no identifiable stone or a stone fragment <4 mm in size that could pass spontaneously. Complications were classified according to the modified Clavien-Dindo grading system. 5 We evaluated the renal function by eGFR levels before and 24 h after the PCNL procedure. The eGFR was calculated by the abbreviated MDRD equation: 186 9 (Cr / 88.4) À 1.154 9 (age) À 0.203 9 (0.742 if female) 9 (1.210 if black). Qualitative data were expressed as numbers and percentages, and quantitative data were presented as mean AE SD or median with IQR. Propensity scoring was used for control of selection bias, and carried out using binary logistic regression to generate a propensity score for each patient who underwent metal dilatation and plasma vaporization. Variables included age, sex, body mass index, stone type, preoperative urinary tract infection and stone size were received propensity score matching. Before propensity score matching, normality was tested with the Kolmogorov-Smirnov test. The difference between metal dilatation and plasma vaporization was compared using the independent t-test, Mann-Whitney U-test, Pearson's v 2 -test or Fisher's exact test. After propensity score matching, data were analyzed by conditional logistic regression, and ORs and their 95% CIs were shown with forest plot. Results were considered statistically significant when the P-value was found to be <0.05. These data were analyzed and used to carry out the calculations by using NCSS 11 and SPSS version 22 (IBM Corporation, Somers, NY, USA).
Results
The patients' baseline characteristics before propensity score matching are shown in Table 1 ; there was no statistically significant difference except for age. The average age of the metal group was younger than that of the plasma group (53.4 vs 57.1 years, P = 0.010). The surgical outcomes are shown in Table 2 . There were significantly shorter hospital stay (2.6 vs 3.8 days, P < 0.01), shorter operating time (66.1 vs 108.1 min, P < 0.01) and no blood transfusion rate (0 vs 4 [3.5%], P = 0.031) in the plasma vaporization group. There were no statistically significant differences in 24-h postoperative hematocrit and hemoglobin drop, 24-h postoperative eGFR change, the rate of residual fragments <4 mm, postoperative complications and time of need for pain control between the two groups; however, four patients received a blood transfusion in the metal dilation group (three after operation and one during operation). These three patients receiving blood transfusion after operation in the metal dilatation group suffered from drops of 24-h postoperative hematocrit and hemoglobin, 13.6 AE 5.6% (18.2, 15.3, 7.4%) and 4.4 AE 1.4 g/dL (5.7, 4.4, 3.0 g/dL), respectively. One patient received a blood transfusion during operation in the metal dilatation group, and his 24-h postoperative hematocrit and hemoglobin drops were 5.7% and 1.7 g/dL, respectively, even after blood transfusion. The stone-free rates in non-staghorn type of the plasma and metal groups were 93.3% and 87.2%, respectively (P = 0.282). There were no statistically significant differences among patients' comorbidities, anticoagulants consumption (Table 3 ) and stone component analysis (Table 4) .
After propensity score matching, the patients' baseline characteristics were as shown in Table 5 . The percentages of stone types in both groups were all the same. There was no statistically significant difference in the patients' baseline characteristics. The surgical outcomes are shown in Table 6 and with a forest plot (Fig. 2 ). There were still statistically significant shorter hospital stay (OR 0.46, 95% CI 0.32-0.66; P < 0.001) and shorter operating time (OR 0.98, 95% CI 0.97-0.99; P < 0.001) in the plasma vaporization group. There were no statistically significant differences between the two groups in 24-h postoperative hematocrit and hemoglobin drop, 24-h postoperative eGFR change, the rate of residual fragments <4 mm, blood transfusion and time of need for pain control. Before and after propensity score matching, there were statistically significant shorter hospital stay and operating time in the plasma vaporization group. The stonefree rates in the non-staghorn type were similar (OR 0.82, 95% CI 0.43-1.54; P = 0.530) between the two groups. All kinds of postoperative complications are listed in Table 7 . There were no major complications (grade >2) in the plasma group.
Discussion
The generally common and always inevitable problem during tract creation in PCNL is bleeding. The blood transfusion rates have been documented with an overall 7%, as calculated in a recent systematic review. 2 In addition, the blood transfusion rate of metal dilatation ranges from 5.9 to 11.6%. 6, 7 In the present study, the blood transfusion rate was 3.5% in the metal dilatation group; however, zero blood transfusion was noted in the plasma vaporization group. Because of the lower blood transfusion rate in both groups, there was no difference in change of hemoglobin from preoperative to postoperative conditions. Before propensity score matching, there was a significantly lower blood transfusion rate (0 vs 4 [3.5%], P = 0.031) in the plasma vaporization group, although there was no significant difference comparing the plasma group (plasma vs metal, OR 0.02, 95% CI 2 9 10 À7 -10 3 ; P = 0.471) after propensity score matching. Noticeably, there were just two blood transfusion cases in the metal dilatation group after propensity score matching. Owing to not all blood transfusion data being included after propensity score matching, this might lead to a different and imprecise result. In fact, three patients who received a blood transfusion after operation in the metal dilatation group suffered from 24-h postoperative hematocrit and hemoglobin drops from 7.4 to 18.2% and 3.0 to 5.7 g/dL, respectively. One patient received a blood transfusion during operation in the metal dilatation group, and his 24-h postoperative hematocrit and hemoglobin drops were 5.7% and 1.7 g/dL, respectively, even after blood transfusion.
There was no significant difference in comorbidities for each group, starting hemoglobin, heart disease, peripheral vascular disease, anticoagulants consumption and so on ( Table 3 ). The antiplatelet agents were stopped 7 days before operation. We always followed the guideline for the most appropriate interval for stopping novel anticoagulants or antiplatelet agents before surgery. 8 In the four patients receiving a blood transfusion, none of them had been taking anticoagulants. The risk of blood transfusion might be associated with increased patient age, operative duration and the presence of a positive preoperative urinary infection already shown. 9 In our pre-propensity score matching, patients' baseline age characteristics in the metal dilatation group were younger. There was no significant difference in preoperative urinary infection between the two groups. Due to the above reasons, we could reasonably infer that the higher blood transfusion rates in the metal dilatation group could be associated with the longer average operative time.
The reasons why the operation time was statistically significantly different (66.1 min in the plasma group vs 108.1 min in the metal group, P < 0.01) were as follows. First, one surgeon (WC Lee) preferred 5-Fr ureteral catheter placement by cystoscopy for large stones and methylene blue instillation for tract creation (19.3%), which takes more time to change position in the metal group. Second, a virtually bloodless vaporization with concomitant coagulation even with large vessels could contribute to plasma vaporization, thus providing a very clear visual field and enabling the operator to differentiate the fascia, muscle, adipose tissue, renal parenchyma and calyx, thereby avoiding renal parenchyma or major vessel injury and shortening operation time. Third, we did not record the time of establishing a working tract in the present retrospective study. However, we recently found that it takes approximately 10 min to enter the collecting system in the plasma group.
There was a significantly shorter hospital stay (2.6 vs 3.8 days, P < 0.01) in the plasma vaporization group. However, there was no difference in the change in hemoglobin, change in renal function, pain or complications between the two groups. Nevertheless, we found that all patients in the plasma group were tubeless, and the rate of nephrostomy tube placement in the metal group was significantly higher (0 vs 64 [56.1%], P < 0.001; Table 2 ). In addition, less bleeding during or after the operation reduces the risk of gross hematuria and flank discomfort, which might be induced by retroperitoneal hematoma. In Taiwan, patients are more reluctant to be discharged if they still suffer from hematuria and flank pain due to the health insurance system reimbursement. These factors can reveal the advantage of shorter hospitalization time in the plasma vaporization group. Plasma vaporization also eliminates radiation exposure as a result of fluoroscopic guidance during the creation of a nephrostomy tract. We could produce a plasma corona on the surface of the spherical electrode by using transurethral resection in a saline system (TURis-PVP; Olympus) mounted with the UES-40 bipolar electrosurgical generator. It permits tissue vaporization in a conductive saline medium and enables concomitant hemostasis. Compared with a conventional monopolar resectoscope mounted with a Collin's knife to dilate the nephrostomy tract, we found that the bipolar electrosurgical generator produced a smooth tract without irregularities or tissue debris and no risk of water intoxication.
There were four cases with a history of nephrolithotomy and no difficulty of tract creation by plasma vaporization in our series. When the multiple tracts were required, we could merely repeat the procedure. Extravasation of normal saline into the retroperitoneal space or subcapsular collection around the kidney would not result in water intoxication or hyponatremia. Some might argue about the adverse effect of fluid extravasation into the retroperitoneal space during vaporization. Low pressure with continuous outflow during vaporization has been maintained due to the larger size of the Amplatz sheath (28-Fr) in regard to the bipolar sheath (26-Fr). The sheath was always in the tract, and was advanced simultaneously with the bipolar resectoscope. Furthermore, no pleural effusions were noted in the bipolar patients; additionally, the bipolar resectoscope can always be inserted into the collecting system within 10 min. The low complication of fluid extravasation in our series might reasonably contribute to the shorter operative time (median operation time <60 min) in the plasma vaporization group.
We used propensity score matching to reduce selection bias. The findings also supported that plasma vaporization for creation of a nephrostomy tract results in shorter hospital stay, shorter operative time, less bleeding and an acceptable rate of stone fragments <4 mm in non-staghorn stones. Nevertheless, the limitation of the present study was being retrospective, and prospective randomized trials for eliminating surgeon preference confounders might need to be carried out. The other limitation of the present study was that the operators in each group were different. In addition, plain KUB was used for measuring residual fragments. It is well known that KUB can overestimate stone-free rate of uric acid stones.
In the present study, selection of the tract creation method depends on the surgeon preference. However, we have shorter hospital stay, operative time, less bleeding, an acceptable rate of stone fragments <4 mm and no major complication in the plasma vaporization group. Therefore, we believe plasma vaporization is a safe and effective method, and a simple solution for creating the nephrostomy tract for PCNL in comparison with other techniques in the present study.
